MicroRNA and Diabetes

Zhiguang Zhou

2010-01-01

Abstract:MicroRNA is a class of short non-coding RNA that has important role in gene regulation.Recent studies have demonstrated that microRNA closely relates to insulin production,secretion,action,and pancreatic islet development,which is crucial for the pathogenesis of diabetes.It has been suggested that microRNA may have potential diagnostic and therapeutic applications in diabetes.

What problem does this paper attempt to address?

Regulatory Roles of MicroRNAs in Diabetes

Juan Feng,Wanli Xing,Lan Xie

DOI: https://doi.org/10.3390/ijms17101729

IF: 5.6

2016-01-01

International Journal of Molecular Sciences

Abstract:MicroRNAs (miRNAs), a class of endogenous small noncoding RNAs in eukaryotes, have been recognized as significant regulators of gene expression through post-transcriptional mechanisms. To date, >2000 miRNAs have been identified in the human genome, and they orchestrate a variety of biological and pathological processes. Disruption of miRNA levels correlates with many diseases, including diabetes mellitus, a complex multifactorial metabolic disorder affecting >400 million people worldwide. miRNAs are involved in the pathogenesis of diabetes mellitus by affecting pancreatic β-cell functions, insulin resistance, or both. In this review, we summarize the investigations of the regulatory roles of important miRNAs in diabetes, as well as the potential of circulating miRNAs as diagnostic markers for diabetes mellitus.
Cost analysis of arterial branching in the cardiovascular systems of man and animals.

M. Zamir

DOI: https://doi.org/10.1016/S0022-5193(86)80021-2

IF: 2.405

1986-05-07

Journal of Theoretical Biology

Abstract:
MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections

Sonia R. Isaacs,Jie Wang,Ki Wook Kim,Congcong Yin,Li Zhou,Qing Sheng Mi,Maria E. Craig

DOI: https://doi.org/10.1007/s11892-016-0819-2

2016-11-14

Current Diabetes Reports

Abstract:Since the discovery of the first mammalian microRNA (miRNA) more than two decades ago, a plethora of miRNAs has been identified in humans, now amounting to more than 2500. Essential for post-transcriptional regulation of gene networks integral for developmental pathways and immune response, it is not surprising that dysregulation of miRNAs is often associated with the aetiology of complex diseases including cancer, diabetes and autoimmune disorders. Despite massive expansion of small RNA studies and extensive investigation in diverse disease contexts, the role of miRNAs in type 1 diabetes has only recently been explored. Key studies using human islets have recently implicated virus-induced miRNA dysregulation as a pivotal mechanism of β cell destruction, while the interplay between miRNAs, the immune system and β cell survival has been illustrated in studies using animal and cellular models of disease. The role of specific miRNAs as major players in immune system homeostasis highlights their exciting potential as therapeutics and prognostic biomarkers of type 1 diabetes.

endocrinology & metabolism
MicroRNAs and Type 2 Diabetes

Jiali Deng,Feifan Guo

DOI: https://doi.org/10.1186/s41544-019-0038-5

2019-01-01

ExRNA

Abstract:MicroRNAs (miRNAs) are non-coding single strand RNAs. MiRNAs are encoded by endogenous genes with a length of about 22 nucleotides. MiRNAs play a vital role in the inhibition of post-transcriptional translation of mRNAs. In recent years, studies have discovered that miRNAs play an essensial role in the pathogenesis of type 2 diabetes. In addition, the discovery of miRNAs in the serum and plasma also provides a potential target for the discovery of disease markers. Taken together, preliminary data suggest a potential role of miRNAs in type 2 diabetes, however more clinical trials need to be studied.
A new frontier for the research of diabetic molecular biology: A microRNAs application in β-cell biology, insulin resistance, diabetes and its complications

Rong-li QIAN,Shi-xin JIN

2011-01-01

Abstract:MicroRNAs(miRNAs) are small 19-23 nucleotide RNA molecules that act as regulators of protein expression by inducing the translational arrest and degradation of messenger RNAs.They are potent drivers of differentiation and development of cells,and their dysregulation has been linked toβ-cell biology,insulin resistance,diabetes and its complications.The miR-375 is directly involved in the regulation of insulin secretion.This study demonstrates that a miRNA could be tightly linked to disease phenotypes.In recent years,dozens of additional miRNAs have been identified as components of pathological pathways.This compile provides 31 miRNAs' application in researches and some pathways of diabetic nephropathy as interesting samples.The purpose of this paper is to introduce a great interests of the readers and authors of CJD on miRNAs research..
Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature

Kosmas Margaritis,Georgia Margioula-Siarkou,Styliani Giza,Eleni P. Kotanidou,Vasiliki Regina Tsinopoulou,Athanasios Christoforidis,Assimina Galli-Tsinopoulou

DOI: https://doi.org/10.3390/ijms222212165

IF: 5.6

2021-11-10

International Journal of Molecular Sciences

Abstract:Type-1 diabetes mellitus (T1DM) is one of the most well-defined and complex metabolic disorders, characterized by hyperglycemia, with a constantly increasing incidence in children and adolescents. While current knowledge regarding the molecules related to the pathogenesis and diagnosis of T1DM is vast, the discovery of new molecules, such as micro ribonucleic acids (micro-RNAs, miRNAs), as well as their interactions with T1DM, has spurred novel prospects in the diagnosis of the disease. This review aims at summarizing current knowledge regarding miRNAs’ biosynthesis and action pathways and their role as gene expression regulators in T1DM. MiRNAs follow a complex biosynthesis pathway, including cleaving and transport from nucleus to cytoplasm. After assembly of their final form, they inhibit translation or cause messenger RNA (mRNA) degradation, resulting in the obstruction of protein synthesis. Many studies have reported miRNA involvement in T1DM pathogenesis, mainly through interference with pancreatic b-cell function, insulin production and secretion. They are also found to contribute to β-cell destruction, as they aid in the production of autoreactive agents. Due to their elevated accumulation in various biological specimens, as well as their involvement in T1DM pathogenesis, their role as biomarkers in early preclinical T1DM diagnosis is widely hypothesized, with future studies concerning their diagnostic value deemed a necessity.

biochemistry & molecular biology,chemistry, multidisciplinary
MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

Lena Eliasson,Jonathan L.S. Esguerra

DOI: https://doi.org/10.2337/dbi19-0016

IF: 7.7

2020-04-13

Diabetes

Abstract:Impaired insulin secretion from the pancreatic β-cells is central in the pathogenesis of type 2 diabetes (T2D), and microRNAs (miRNAs) are fundamental regulatory factors in this process. Differential expression of miRNAs contributes to β-cell adaptation to compensate for increased insulin resistance, but deregulation of miRNA expression can also directly cause β-cell impairment during the development of T2D. miRNAs are small noncoding RNAs that posttranscriptionally reduce gene expression through translational inhibition or mRNA destabilization. The nature of miRNA targeting implies the presence of complex and large miRNA–mRNA regulatory networks in every cell, including the insulin-secreting β-cell. Here we exemplify one such network using our own data on differential miRNA expression in the islets of T2D Goto-Kakizaki rat model. Several biological processes are influenced by multiple miRNAs in the β-cell, but so far most studies have focused on dissecting the mechanism of action of individual miRNAs. In this Perspective we present key islet miRNA families involved in T2D pathogenesis including miR-200, miR-7, miR-184, miR-212/miR-132, and miR-130a/b/miR-152. Finally, we highlight four challenges and opportunities within islet miRNA research, ending with a discussion on how miRNAs can be utilized as therapeutic targets contributing to personalized T2D treatment strategies.
Relationship between Circulating miRNA and Type 2 Diabetes

Jia-lu CAI,Cheng WANG,Jun-jun WANG

DOI: https://doi.org/10.3969/j.issn.1671-7414.2015.03.002

2015-01-01

Abstract:MicroRNAs (miRNAs)are a class of small non-coding RNA that regulate gene expression at the posttranscrip-tional level and play important roles in cell proliferation,differentiation,apoptosis and metabolism.Moreover,specific miR-NAs can be secreted or released from tissues and cells in different physiological or pathological statusand enteredinto blood circulation,and secreted miRNAs can be delivered into recipient cells and emerged as powerful regulatorsof a wide range of biological processes.Many recent studieshave shown that miRNAswere involved in the development and progression of type 2 diabetes (T2DM).Due to the widely source,highly stability,and specific expression patternunder different physiological or pathological conditions,circulating miRNAs may serve as a novelbiomarker for T2DM and may also participate in the devel-opment of type 2 diabetes.
Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Zhou, Hong

DOI: https://doi.org/10.1007/s13258-023-01403-8

2023-05-31

Abstract:Background MicroRNAs (miRNAs) can regulate expression of target genes at post transcriptional level, and mediate the pathophysiological process of many diseases. Objective The study will illuminate the miRNA expression profiles of diabetic cardiomyopathy (DCM), seeking probable biomarkers of DCM at early stage and determining a target for the treatment of DCM. Methods Db/db mice were used as an animal model of type 2 diabetes mellitus. At 22 weeks of age, cardiac function was evaluated by echocardiography, and the structural changes in myocardium were evaluated by HE staining and TEM. The miRNA expression profiles were detected using miRNA sequencing and differentially expressed miRNAs were validated by real-time PCR. Bioinformatic analysis was used to analyze target genes of these miRNAs and relevant pathways in DCM. Results The results showed that 40 miRNAs were differentially expressed, including 28 upregulated miRNAs and 12 downregulated miRNAs. GO and KEGG pathway analysis showed that the target genes of up-regulated miRNAs were involved in 66 pathways, including Wnt, p53 and calcium signaling pathways, as well as FOXO and apoptosis signaling pathways, etc. The target genes of down-regulated miRNAs were involved in 68 pathways, including mitophagy, Ras and MAPK signaling pathways, etc. Moreover, some differentially expressed miRNAs were found in myocardium of DCM for the first time, such as miR-7225-5p, miR-696, miR-3470a, miR-3470b, miR-6240, miR-6538, miR-5128, miR-1195, miR-203-3p and miR-330-5p. Conclusions It is hoped that a few novel molecular pathways or targets of treatment for DCM would be found through understanding the expression features of miRNAs in diabetic myocardium.

genetics & heredity,biochemistry & molecular biology,biotechnology & applied microbiology
Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications

Mahyar Ghaffari,Sara Razi,Hamidreza Zalpoor,Mohsen Nabi-Afjadi,Fariba Mohebichamkhorami,Hakimeh Zali

DOI: https://doi.org/10.1155/2023/2587104

IF: 4.0608

2023-03-05

Journal of Diabetes Research

Abstract:Most medical investigations have found a reduced blood level of miR-146a in type 2 diabetes (T2D) patients, suggesting an important role for miR-146a (microRNA-146a) in the etiology of diabetes mellitus (DM) and its consequences. Furthermore, injection of miR-146a mimic has been confirmed to alleviate diabetes mellitus in diabetic animal models. In this line, deregulation of miR-146a expression has been linked to the progression of nephropathy, neuropathy, wound healing, olfactory dysfunction, cardiovascular disorders, and retinopathy in diabetic patients. In this review, besides a comprehensive review of the function of miR-146a in DM, we discussed new findings on type 1 (T1MD) and type 2 (T2DM) diabetes mellitus, highlighting the discrepancies between clinical and preclinical investigations and elucidating the biological pathways regulated through miR-146a in DM-affected tissues.

endocrinology & metabolism,medicine, research & experimental
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

Mitsuo Kato,Rama Natarajan

DOI: https://doi.org/10.1111/nyas.12758

IF: 6.499

2015-04-15

Annals of the New York Academy of Sciences

Abstract:MicroRNAs (miRNAs) are short noncoding RNAs that regulate gene expression by posttranscriptional and epigenetic mechanisms and thereby affect many cellular processes and disease states. Over 2,000 human mature miRNAs have been identified, and at least 60% of all human protein-coding genes are known to be regulated by miRNAs. MicroRNA biogenesis involves classical transcription regulation and processing by key ribonucleases, as well as other protein factors and epigenetic mechanisms. Diabetic nephropathy (DN), a severe microvascular complication frequently associated with diabetes mellitus, is a major cause of renal failure. Although several mechanisms of regulation of key renal genes implicated in DN pathogenesis have been identified, a greater understanding is needed to develop better treatment modalities. Recent studies show that miRNAs induced in renal cells in vivo and in vitro under diabetic conditions can promote the accumulation of extracellular matrix proteins related to fibrosis and glomerular dysfunction. In this review, we highlight the significance of the expression of miRNAs in various stages of DN and emerging approaches to exploit them as biomarkers for early detection or novel therapeutic targets to prevent progression of DN.

multidisciplinary sciences
Subcellular microRNAs in diabetic cardiomyopathy

Huaping Li,Jiahui Fan,Chen Chen,Dao Wen Wang

DOI: https://doi.org/10.21037/atm-20-2205

IF: 3.616

2020-12-01

Annals of Translational Medicine

Abstract:Cardiovascular complications are the leading causes of diabetes-related morbidity and mortality. The high incidence and poor prognosis of heart failure in diabetic patients have been associated, in part, to the presence of an underlying cardiomyopathy characterized by cardiac hypertrophy, cardiomyocytes apoptosis, and fibrosis. It has been unclear about the mechanism that connects diabetes mellitus to the development of cardiovascular dysfunction. Micro(mi)RNAs represent a class of small, 18- to 28-nucleotide-long, non-coding RNA molecules. MiRNAs typically suppress gene expression at the post-transcriptional levels by binding directly to the 3'-UTR of the target mRNAs in the cytoplasm. Interestingly, recent studies suggest that miRNAs may also regulate gene expression in a positive manner. Our recent studies have shown that subcellular miRNAs, such as cytosol-, mitochondria- and nucleus-localized miRNAs, were dramatically dysregulated in diabetic cardiomyopathy. Specifically, cytoplasm localized miRNAs regulate genes expression in a post-transcriptional manner. Nuclear localized miRNAs regulate gene transcription or chromosomal reconstruction through the non-canonical mechanism. Mitochondrial miRNAs stimulate, rather than repress, the translation of specific mitochondrial genome-encoded transcripts. By reviewing these latest discovered functions of subcellular miRNAs in diabetic animal models, we identified new mechanistic insights for diabetic cardiomyopathy. Understanding the nature of subcellular miRNAs will provide new therapeutic targets against diabetes-associated cardiac complications in the near future.

oncology,medicine, research & experimental
MicroRNAs and their delivery in diabetic fibrosis

Alexa Wonnacott,Laura Denby,Richard J M Coward,Donald J Fraser,Timothy Bowen

DOI: https://doi.org/10.1016/j.addr.2021.114045

Abstract:The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019 and is predicted to rise to 700 million by 2045. The associated financial and societal costs of this burgeoning epidemic demand an understanding of the pathology of this disease, and its complications, that will inform treatment to enable improved patient outcomes. Nearly two decades after the sequencing of the human genome, the significance of noncoding RNA expression is still being assessed. The family of functional noncoding RNAs known as microRNAs regulates the expression of most genes encoded by the human genome. Altered microRNA expression profiles have been observed both in diabetes and in diabetic complications. These transcripts therefore have significant potential and novelty as targets for therapy, therapeutic agents and biomarkers.
Role of MicroRNA in linking diabetic retinal neurodegeneration and vascular degeneration

Haiyan Zhao,Yichen Cai,Junhua Pan,Qiu Chen

DOI: https://doi.org/10.3389/fendo.2024.1412138

2024-07-04

Abstract:Diabetic retinopathy is the major cause of blindness in diabetic patients, with limited treatment options that do not always restore optimal vision. Retinal nerve degeneration and vascular degeneration are two primary pathological processes of diabetic retinopathy. The retinal nervous system and vascular cells have a close coupling relationship. The connection between neurodegeneration and vascular degeneration is not yet fully understood. Recent studies have found that microRNA plays a role in regulating diabetic retinal neurovascular degeneration and can help delay the progression of the disease. This article will review how microRNA acts as a bridge connecting diabetic retinal neurodegeneration and vascular degeneration, focusing on the mechanisms of apoptosis, oxidative stress, inflammation, and endothelial factors. The aim is to identify valuable targets for new research and clinical treatment of diabetic retinopathy.
Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic Β- and Α-Cells

Ramkumar Mohan,Yiping Mao,Shungang Zhang,Yu-Wei Zhang,Cheng-Ran Xu,Gerard Gradwohl,Xiaoqing Tang

DOI: https://doi.org/10.1074/jbc.m115.650705

2015-01-01

Abstract:Background: MicroRNAs are noncoding RNAs and have emerged as important regulators in β-cell function. Results: miR-483 is highly expressed in β-cells but expressed at much lower levels in α-cells, and increased miR-483 induces insulin production in β-cells while repressing glucagon production in α-cells. Conclusion: miR-483 has opposite effects in α- and β-cells by targeting SOCS3. Significance: miR-483 is a potential therapeutic target for diabetes. Insulin secreted from pancreatic β-cells and glucagon secreted from pancreatic α-cells are the two major hormones working in the pancreas in an opposing manner to regulate and maintain a normal glucose homeostasis. How microRNAs (miRNAs), a population of non-coding RNAs so far demonstrated to be differentially expressed in various types of cells, regulate gene expression in pancreatic β-cells and its closely associated α-cells is not completely clear. In this study, miRNA profiling was performed and compared between pancreatic β-cells and their partner α-cells. One novel miRNA, miR-483, was identified for its highly differential expression in pancreatic β-cells when compared to its expression in α-cells. Overexpression of miR-483 in β-cells increased insulin transcription and secretion by targeting SOCS3, a member of suppressor of cytokine signaling family. In contrast, overexpression of miR-483 decreased glucagon transcription and secretion in α-cells. Moreover, overexpressed miR-483 protected against proinflammatory cytokine-induced apoptosis in β-cells. This correlates with a higher expression level of miR-483 and the expanded β-cell mass observed in the islets of prediabetic db/db mice. Together, our data suggest that miR-483 has opposite effects in α- and β-cells by targeting SOCS3, and the imbalance of miR-483 and its targets may play a crucial role in diabetes pathogenesis.
The Factor Analysis's Applicability on Social Indicator Research

Ying Xie,Yao-Hua Chen,Ling Peng

DOI: https://doi.org/10.3233/978-1-61499-722-1-254

Abstract:
MicroRNA and obesity

Junqi Shi,Chaochun Zou

DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2015.05.014

2015-01-01

International Journal of Endocrinology and Metabolism

Abstract:Recent researches have proved that microRNA in adipose tissue and peripheral blood participates in the progress of adipocyte differentiation,insulin resistance,lipid metabolism and so on,which are closely associated with obesity.The molecular mechanisms of micmRNA on obesity have been discovered step by step.For example,transcription factors and signaling molecules related to the multiplication and differentiation of adipocytes are regulated and controlled by enhancing or restraining of relevant gene expression.The investigation of the mechanisms provides a new approach for precaution and treatment of obesity and obesity-related metabolic diseases.
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?

G. Sebastiani,L. Nigi,G. E. Grieco,F. Mancarella,G. Ventriglia,F. Dotta

DOI: https://doi.org/10.1007/s40618-017-0611-4

2017-02-17

Journal of Endocrinological Investigation

Abstract:Diabetes is a complex, multifactorial group of metabolic diseases characterized by chronic hyperglycaemia due to pancreatic beta-cell dysfunction and/or loss. It is characterized by an asymptomatic and highly variable prodromic phase, which renders diabetes mellitus difficult to be predicted with sufficient accuracy. Despite several efforts in the identification and standardization of newly trustable. Biomarkers able to predict and follow-up diabetes and to specifically subtype its different forms, few of them have proven of clinical utility. Recently, a new class of endogenous non-coding small RNAs, namely microRNAs, have been indicated as putative biomarkers, being released by cells and tissues and found in a cell-free circulating form in many biological fluids, including serum and/or plasma. MicroRNAs have been initially identified as promising biomarkers in cancer, and nowadays their application has been extended to other diseases, including diabetes. Although an increasing number of studies focused on the evaluation of circulating microRNAs in diabetes, few reproducibly identified microRNAs as biomarkers for disease prediction or follow-up. Technological problems as well as the need to obtain highly standardized operating procedures and methods are still an issue in such research field. In this review, we comprehensively resume the main and most recent findings on circulating microRNAs, and their possible use as biomarkers to predict and follow-up diabetes and its complications, as well as the methodological challenges to standardize accurate operating procedures for their analysis.

endocrinology & metabolism
MicroRNA‐29‐mediated cross‐talk between metabolic organs in the pathogenesis of diabetes mellitus and its complications: A narrative review

Hassen Ahmed Yesuf,Meseret Derbew Molla,Tabarak Malik,Zeru Seyoum Wendimagegn,Yadelew Yimer

DOI: https://doi.org/10.1002/cbf.4053

2024-05-23

Cell Biochemistry and Function

Abstract:Diabetes mellitus (DM) is a heterogeneous group of disorders characterized by hyperglycemia. Microribonucleic acids (microRNAs) are noncoding RNA molecules synthesized in the nucleus, modified, and exported to the extracellular environment to bind to their complementary target sequences. It regulates protein synthesis in the targeted cells by inhibiting translation or triggering the degradation of the target messenger. MicroRNA‐29 is one of noncoding RNA that can be secreted by adipose tissue, hepatocytes, islet cells, and brain cells. The expression level of the microRNA‐29 family in several metabolic organs is regulated by body weight, blood concentrations of inflammatory mediators, serum glucose levels, and smoking habits. Several experimental studies have demonstrated the effect of microRNA‐29 on the expression of target genes involved in glucose metabolism, insulin synthesis and secretion, islet cell survival, and proliferation. These findings shed new light on the role of microRNA‐29 in the pathogenesis of diabetes and its complications, which plays a vital role in developing appropriate therapies. Different molecular pathways have been proposed to explain how microRNA‐29 promotes the development of diabetes and its complications. However, to the best of our knowledge, no published review article has summarized the molecular mechanism of microRNA‐29‐mediated initiation of DM and its complications. Therefore, this narrative review aims to summarize the role of microRNA‐29‐mediated cross‐talk between metabolic organs in the pathogenesis of diabetes and its complications.

cell biology,biochemistry & molecular biology
The revising of the Tangney Self-Control Scale for Chinese students.

Alexander Unger,Chongzeng Bi,Yingying Xiao,O. Ybarra

DOI: https://doi.org/10.1002/pchj.128

IF: 1.559

2016-06-01

PsyCh Journal

Abstract:Recent studies have characterized self-control as a vital psychological variable that helps explain various problems. Tangney's Self-Control Scale (SCS) is a self-report measurement to assess individual differences in traits of self-control. It has gained popularity in social and psychological science research. In China, there are a few Chinese-version scales measuring general self-control, which can be applied to college students. The purposes of the present study were to evaluate: (a) the psychometric properties of the Chinese version of Tangney's SCS using confirmatory factor analysis, and (b) whether higher scores on the scale correlated with positive outcomes in China. The final sample in this study consisted of 371 Chinese college students aged 17-23 years. The Full SCS and Brief SCS were both found to have a reasonable fitness, which also had satisfactory internal consistencies and a high correlation. Higher scores on the SCS correlated with higher self-esteem, extraversion, better harmony in interpersonal relationships and an appropriate anger expression, less impulsiveness, and state and trait anger. The test-retest reliability was confirmed in two additional samples. Tangney's SCS could be used in China.

MicroRNA and Diabetes

Regulatory Roles of MicroRNAs in Diabetes

Cost analysis of arterial branching in the cardiovascular systems of man and animals.

MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections

MicroRNAs and Type 2 Diabetes

A new frontier for the research of diabetic molecular biology: A microRNAs application in β-cell biology, insulin resistance, diabetes and its complications

Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature

MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

Relationship between Circulating miRNA and Type 2 Diabetes

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications

MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

Subcellular microRNAs in diabetic cardiomyopathy

MicroRNAs and their delivery in diabetic fibrosis

Role of MicroRNA in linking diabetic retinal neurodegeneration and vascular degeneration

Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic Β- and Α-Cells

The Factor Analysis's Applicability on Social Indicator Research

MicroRNA and obesity

Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?

MicroRNA‐29‐mediated cross‐talk between metabolic organs in the pathogenesis of diabetes mellitus and its complications: A narrative review

The revising of the Tangney Self-Control Scale for Chinese students.